Ukraine’s military announced that it successfully struck military targets within Russia using US-supplied ATACMS missiles, a significant development in the ongoing conflict. This marks the first public acknowledgment of using these advanced ballistic missile systems against Russian territory, following the lifting of previous restrictions by the Biden administration in late 2024. Kyiv received the ATACMS in 2023 but was initially limited to using them within its own borders. Ukraine has also expressed interest in acquiring Tomahawk missiles, which have a longer range, to further pressure Russia.
Read More
President Zelenskyy stated that Ukraine is solely employing its own domestically produced long-range weapons to strike targets within Russian territory. This statement was made in response to inquiries regarding Western media reports, specifically one from The Wall Street Journal, suggesting the US had imposed restrictions on the use of ATACMS missiles. Zelenskyy indicated that such limitations are not currently a topic of discussion with the United States, contrasting with past instances where discussions regarding retaliatory strikes were more prevalent. This is a shift from previous practice.
Read More
Reports indicate that US defense officials have restricted Ukraine’s use of long-range missiles, including the US-made ATACMS, against targets within Russia. This restriction, implemented since late spring, is part of an effort to encourage Vladimir Putin to engage in peace talks, according to sources. The Pentagon employs a review mechanism to govern the use of US long-range weapons, effectively granting approval authority to Defense Secretary Pete Hegseth. This policy shift follows former President Trump’s criticism of allowing Ukraine to strike inside Russia.
Read More
The Pentagon has reportedly been restricting Ukraine from using U.S.-made ATACMS to strike targets within Russia, according to a report by the Wall Street Journal. This decision limits Kyiv’s use of these weapons against Moscow’s invasion. This news comes amidst increasing frustration from U.S. President Donald Trump regarding the ongoing war and the lack of progress in peace negotiations. Trump is now considering imposing further sanctions on Russia or potentially withdrawing from the peace process altogether, as efforts to arrange a meeting between Putin and Zelenskiy have proven unsuccessful.
Read More
Democratic senators, led by Elizabeth Warren, are demanding answers from Mehmet Oz regarding his past advocacy for Medicare privatization, specifically his 2020 proposal to transition all seniors to Medicare Advantage. The letter highlights concerns about Oz’s financial ties to private insurers, including significant stock holdings in UnitedHealth, a company under federal investigation. Senators question Oz’s commitment to traditional Medicare and his potential conflicts of interest if confirmed to lead CMS. The letter foreshadows a contentious confirmation process, with Democrats demanding assurances against Medicare privatization and full divestment from the insurance industry.
Read More
Intelligence assessments consistently indicate that providing Ukraine with longer-range U.S. weapons, such as the ATACMS, does not significantly increase the risk of a Russian nuclear attack, despite Kremlin rhetoric to the contrary. This conclusion informed the Biden administration’s decision to authorize their use, a move intended to bolster Ukraine’s negotiating position. However, Russia is anticipated to intensify sabotage efforts against European infrastructure, and a potential Trump presidency poses a considerable threat to continued U.S. support for Ukraine. The ongoing war also presents challenges for Ukraine including battlefield losses and potential foreign troop deployments.
Read More
Utilizing open-source intelligence, analysts confirmed the first Ukrainian use of US-provided ATACMS missiles, specifically those with cluster warheads, targeting the Kursk-Vostochny airfield in Russia’s Kursk Oblast on November 24-25. Evidence included photographic proof of submunition detonation within the airfield’s aircraft parking area, corroborated by a Russian military blogger. The strike, reportedly involving eight missiles, followed President Biden’s authorization of ATACMS use against Russia. This represents a significant escalation in the conflict.
Read More
Ukraine successfully targeted a Russian command post in Gubkin, Belgorod Oblast, approximately 168 kilometers from the Ukrainian border. This follows President Biden’s authorization of long-range ATACMS missile strikes into Russia, with this attack marking the first confirmed use of these missiles against a Russian command post. Reports indicate significant damage and corroborate Ukrainian claims, despite Russian denials and interception claims. The strike occurred amidst heightened tensions, including the reported deployment of North Korean troops to the Ukrainian front and the closure of the U.S. Embassy in Kyiv due to a potential air attack threat.
Read More
The Biden administration’s authorization of long-range ATACMS strikes inside Russia represents a significant policy shift, potentially bolstering Ukraine’s defense against a large Russian-North Korean force. This action, likely influenced by the upcoming Trump presidency, allows Ukraine to target key Russian infrastructure, such as command centers and logistics, thereby weakening their offensive capabilities. Retired General Ben Hodges emphasizes that while not a “game changer” in itself, the ATACMS authorization is a positive step, although its restricted use remains a concern. However, the long-term impact remains uncertain given President-elect Trump’s stated intentions to quickly end the war, raising concerns about future U.S. support for Ukraine.
Read More
President-elect Trump’s nomination of Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services (CMS) is raising concerns. Dr. Oz, a celebrity physician with limited relevant experience, supports Medicare privatization and expansion of Medicare Advantage, a position opposed by many. This contrasts sharply with CMS’s complex regulatory role overseeing healthcare for 150 million Americans. Critics argue his background in promoting unproven treatments makes him an unsuitable candidate. The potential consequences of his confirmation include further privatization of Medicare and increased costs for taxpayers.
Read More
John Q. Hosedrinker